CVS HEALTH CORPORATION (CVS) FY2023 Annual P&L / Income Statement

CVS HEALTH CORPORATION (CVS) FY2023 Annual P&L / Income Statement

Income statement for 2023-01-01 through 2023-12-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

357,776,000,000 US dollars

Total operating costs

344,033,000,000 US dollars

Operating income

13,743,000,000 US dollars

Other income (expense), net (calculated)

negative 2,570,000,000 US dollars

Income before income tax provision

11,173,000,000 US dollars

Income tax provision

2,805,000,000 US dollars

Net income

8,368,000,000 US dollars

Health Care Benefits

105,646,000,000 US dollars

Health Services

186,843,000,000 US dollars

Pharmacy & Consumer Wellness

116,763,000,000 US dollars

Cost of products sold

217,098,000,000 US dollars

Health care costs

86,247,000,000 US dollars

Restructuring charges

507,000,000 US dollars

Opioid litigation charges

0 US dollars

Loss on assets held for sale

349,000,000 US dollars

Store impairments

0 US dollars

Goodwill impairment

0 US dollars

Operating expenses

39,832,000,000 US dollars

Revenue before reconciliation (calculated)

409,252,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Intersegment Eliminations

negative 51,927,000,000 US dollars. Reported reconciliation to consolidated revenue.

Corporate/ Other

451,000,000 US dollars. Reported reconciliation to consolidated revenue.

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
• Of which attributable to CVS HEALTH CORPORATION: $8.34 B; to noncontrolling interests: $24.00 M.